Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
10.12.23 | Incyte and Syndax Pharmaceuticals: Incyte and Syndax Present Additional Data from Positive AGAVE-201 Trial at ASH Plenary Session Showing Axatilimab Efficacy Including Durable Responses in Chronic Graft-Versus-Host Disease | 685 | Business Wire | Trial met its primary endpoint across all dose cohorts with 74% of patients at the 0.3 mg/kg dose achieving a complete or partial response within the first six months of treatment
Data are featured... ► Artikel lesen | |
10.12.23 | Innate Pharma SA: Innate Pharma Presents Positive Results From TELLOMAK Phase 2 Study With Lacutamab in Patients With Sézary Syndrome at ASH 2023 | 692 | Business Wire | Results confirm promising clinical activity, durable responses and favorable safety of lacutamab in heavily pretreated post-mogamulizumab Sézary Syndrome patients. Virtual KOL event will... ► Artikel lesen | |
10.12.23 | Belgian, Port Houston and Partners Sign Memorandum of Understanding on Energy Transition Cooperation | 476 | Business Wire | Today, H.E. Alexander De Croo, Prime Minister of Belgium, witnessed the signing of a Memorandum of Understanding on Energy Transition Cooperation between three Belgian and three Houston-based partners... ► Artikel lesen |
Suchbegriffe der letzen 24 h | Anzahl |
---|---|
GAMESTOP | 5.587 |
EVOTEC | 4.781 |
TUI | 3.589 |
NEL | 2.781 |
PLUG POWER | 2.166 |
BAYER | 2.155 |
NVIDIA | 2.118 |
AMC ENTERTAINMENT | 2.093 |
SIEMENS ENERGY | 1.962 |
RHEINMETALL | 1.915 |
DEUTSCHE BANK | 1.707 |
RENK GROUP | 1.443 |
SIEMENS | 1.383 |
COMMERZBANK | 1.370 |
ALIBABA | 1.306 |
HEIDELBERGER DRUCK | 1.305 |
AIXTRON SE | 1.289 |
VOLKSWAGEN | 1.155 |
BYD | 1.138 |
MERCEDES-BENZ | 1.130 |
SUPER MICRO COMPUTER | 1.091 |
DEUTSCHE TELEKOM | 1.080 |
RWE | 1.053 |
ALLIANZ | 1.032 |
DEUTSCHE LUFTHANSA | 961 |